Follow
Jahangir Abdi
Title
Cited by
Cited by
Year
Drug resistance in multiple myeloma: latest findings and new concepts on molecular mechanisms
J Abdi, G Chen, H Chang
Oncotarget 4 (12), 2186, 2013
2912013
miR-137 and miR-197 induce apoptosis and suppress tumorigenicity by targeting MCL-1 in multiple myeloma
Y Yang, F Li, MN Saha, J Abdi, L Qiu, H Chang
Clinical cancer research 21 (10), 2399-2411, 2015
1242015
Omega-3 fatty acids, EPA and DHA induce apoptosis and enhance drug sensitivity in multiple myeloma cells but not in normal peripheral mononuclear cells
J Abdi, J Garssen, J Faber, FA Redegeld
The Journal of nutritional biochemistry 25 (12), 1254-1262, 2014
862014
Dysregulation of EZH2/miR-138 axis contributes to drug resistance in multiple myeloma by downregulating RBPMS
N Rastgoo, M Pourabdollah, J Abdi, D Reece, H Chang
Leukemia 32 (11), 2471-2482, 2018
642018
Role of epigenetics-microRNA axis in drug resistance of multiple myeloma
N Rastgoo, J Abdi, J Hou, H Chang
Journal of hematology & oncology 10, 1-10, 2017
622017
Role of tumor suppressor p53 and micro-RNA interplay in multiple myeloma pathogenesis
J Abdi, N Rastgoo, L Li, W Chen, H Chang
Journal of hematology & oncology 10, 1-11, 2017
532017
Characterization of the Toll-like receptor expression profile in human multiple myeloma cells
J Abdi, T Mutis, J Garssen, F Redegeld
PloS one 8 (4), e60671, 2013
452013
Role of micro-RNAs in drug resistance of multiple myeloma
J Abdi, H Jian, H Chang
Oncotarget 7 (37), 60723, 2016
422016
Concise review: TLR pathway-miRNA interplay in mesenchymal stromal cells: regulatory roles and therapeutic directions
J Abdi, I Rashedi, A Keating
Stem cells 36 (11), 1655-1662, 2018
402018
MiRNA-29a as a tumor suppressor mediates PRIMA-1Met-induced anti-myeloma activity by targeting c-Myc
MN Saha, J Abdi, Y Yang, H Chang
Oncotarget 7 (6), 7149, 2016
352016
Micro-RNAs, New performers in multiple myeloma bone marrow microenvironment
J Abdi, L Qiu, H Chang
Biomarker research 2, 1-6, 2014
342014
PRIMA-1Met induces apoptosis in Waldenström's Macroglobulinemia cells independent of p53
M Sobhani, J Abdi, SN Manujendra, C Chen, H Chang
Cancer biology & therapy 16 (5), 799-806, 2015
292015
Ectopic expression of BIRC5-targeting miR-101-3p overcomes bone marrow stroma-mediated drug resistance in multiple myeloma cells
J Abdi, N Rastgoo, Y Chen, GA Chen, H Chang
BMC cancer 19, 1-12, 2019
252019
The role of toll-like receptor mediated signalling in the pathogenesis of multiple myeloma
J Abdi, F Engels, J Garssen, F Redegeld
Critical reviews in oncology/hematology 80 (2), 225-240, 2011
252011
Toll-like receptor (TLR)-1/2 triggering of multiple myeloma cells modulates their adhesion to bone marrow stromal cells and enhances bortezomib-induced apoptosis
J Abdi, T Mutis, J Garssen, FA Redegeld
PloS one 9 (5), e96608, 2014
212014
Over expression of HIF-1α in human mesenchymal stem cells increases their supportive functions for hematopoietic stem cells in an experimental co-culture model
AA Kiani, J Abdi, R Halabian, MH Roudkenar, N Amirizadeh, ...
Hematology 19 (2), 85-98, 2014
212014
Toll-like receptors in human multiple myeloma: new insight into inflammation-related pathogenesis
J Abdi, J Garssen, F Redegeld
Current Molecular Medicine 14 (4), 423-431, 2014
132014
Stimulation of Toll-like receptor-1/2 combined with Velcade increases cytotoxicity to human multiple myeloma cells
J Abdi, T Mutis, J Garssen, F Redegeld
Blood cancer journal 3 (5), e119-e119, 2013
122013
Prevalence of alloimmunization against RBC antigens in thalassemia major patients of Lorestan province in 1383
A Kiani, J Abdi, Y Shirkhani, M Kashi
Scientific Journal of Iran Blood Transfus Organ 3 (3), 265-271, 2006
112006
Seroepidemiologic evaluation of Rh system major antigens (D, C, E, c, e) and their phenotypes among the blood donors in Khorramabad, Iran
J ABDI, ALIA KIANI
THE SCIENTIFIC JOURNAL OF IRANIAN BLOOD TRANSFUSION ORGANIZATION (KHOON) 6 …, 2009
72009
The system can't perform the operation now. Try again later.
Articles 1–20